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Abstract
Zerumbone is a sesquiterpene present in Zinger zerumbet. Many studies have demon-
strated its marked anti-inflammatory and anti-carcinogenesis activities. Recently, we
showed that zerumbone binds to numerous proteins with scant selectivity and induces the
expression of heat shock proteins (HSPs) in hepatocytes. To dampen proteo-toxic stress,
organisms have a stress-responsive molecular machinery, known as heat shock response.
Heat shock factor 1 (HSF1) plays a key role in this protein quality control system by promot-
ing activation of HSPs. In this study, we investigated whether zerumbone-induced HSF1
activation contributes to its anti-inflammatory functions in stimulated macrophages. Our
findings showed that zerumbone increased cellular protein aggregates and promoted
nuclear translocation of HSF1 for HSP expression. Interestingly, HSF1 down-regulation
attenuated the suppressive effects of zerumbone on mRNA and protein expressions of pro-
inflammatory genes, including inducible nitric oxide synthase and interlukin-1β. These
results suggest that proteo-stress induced by zerumbone activates HSF1 for exhibiting its
anti-inflammatory functions.
Introduction
Zerumbone is a sesquiterpenoid present in the subtropical ginger Zingiber zerumbet Smith, a
plant that has been traditionally utilized in Southeast Asia for various purposes, including anti-
inflammatory medicine. Recent in vitro and in vivo studies have revealed several biological
properties of this phytochemical, e.g., inhibitory effects toward free radical generation, expres-
sion of pro-inflammatory genes, such as inducible nitric oxide synthase (iNOS) and cyclooxy-
genase-2 (COX-2), and carcinogenesis [1–7]. Although the underlying molecular mechanisms
of its cancer preventive activity have not been fully elucidated, we previously reported that zer-
umbone activated nuclear factor erythroid 2-related factor-2 (Nrf2) presumably by binding to
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Kelch-like ECH-associated protein 1 (Keap1), the key regulator of Nrf2 activation [8,9]. This
binding may occur at its α,β-unsaturated carbonyl group, which can react with a nucleophilic
group. On the other hand, our experiments using antibodies (Abs) against zerumbone-adducts
showed that it binds to various cellular proteins with low selectivity [10]. Because treatment of
cellular proteins in vitro with zerumbone leads to their insolubilization [10,11], such non-spe-
cific protein modifications are expected to cause proteo-toxic stress in cells.
Denatured proteins tend to form aggregates, in which their surface-exposed hydrophobic
domains interact with each other, and accumulation of these abnormal proteins is related to
onset of various conditions such as neurodegenerative disease [12]. In organisms, there are
mechanisms to maintain protein homeostasis and prevent accumulation of protein aggregates,
which are collectively termed protein quality control (PQC) systems [13]. Denatured proteins
are recognized and then repaired by molecular chaperones, including heat shock proteins
(HSPs) [12], while excessively denatured proteins undergo ubiquitination and are degraded
through intracellular proteolytic machineries, including the ubiquitin-proteasome system
(UPS) and autophagy [13]. Expression of HSPs induced by environmental or pathophysiologi-
cal stress is largely regulated by heat shock factor 1 (HSF1), a transcriptional factor. Although
HSF1 is sequestered in cytosol by binding with constitutive HSP90 under normal conditions,
under cellular stress conditions, such as heat, hypoxia, and ethanol, HSP90 is recruited to dena-
tured proteins, which cause a release of HSF1 to translocate to the nucleus and promote tran-
scription of inducible HSPs. This process is known as heat shock response (HSR). Moreover,
recent studies have revealed that HSF1 regulates various genes related to suppression of inflam-
mation, as well as aging and cancer in stressed and non-stressed cells, indicating its importance
as a master transcriptional factor in homeostasis [14–16]. In support of this notion, HSF1
knockdown has been reported to exacerbate pro-inflammatory responses via the activation of
nuclear factor-κB (NF-κB) and activator protein-1 (AP-1) [17]. These transcriptional factors
play important roles in inflammation and carcinogenesis, thus are considered to be promising
targets for treatment of those pathologies [17]. Additionally, intracellular HSP70 induced by
HSF1 has also been reported to possess an anti-inflammatory function in macrophages, while
extracellular HSP70 plays a pro-inflammatory role [18].
Our previous study showed that zerumbone promotes ubiquitination and aggregation of cel-
lular proteins in Hepa1c1c7 mouse hepatoma cells, which indicated its potential proteo-toxicity
[11]. Furthermore, zerumbone has been shown to increase the expression of HSPs (HSP40,
HSP70, HSP90) through HSF1 activation, and enhance the intracellular proteolysis mechanisms
of UPS and autophagy, both of which are activated by zerumbone-induced proteo-stress for
removing denatured proteins [10,11]. In the present study, we investigated whether HSF1 activa-
tion induced by zerumbone contributes to its anti-inflammatory functions in lipopolysaccharide
(LPS)-stimulated RAW264.7 mouse macrophages. Interestingly, HSF1 down-regulation was
found to significantly attenuate its suppressive effects on mRNA and protein expressions of
iNOS and interleukin (IL)-1β. These results suggest that proteo-stress induced by zerumbone
activates HSF1 for exhibiting its anti-inflammatory functions in macrophages.
Materials and Methods
Reagents
Dulbecco’s modified eagle medium (DMEM) and Opti-MEM1 were purchased from Life
Technologies (Grand Island, NY), and fetal bovine serum (FBS) from Biological Industries
(Beit HaEmek, Israel). Zerumbone was purified (>95%) as previously reported [1], briefly,
fresh rhizomes of Z. zerumbet were extracted with methanol at room temperature and concen-
trated in vacuo. The aqueous extract was then partitioned between chloroform and deionized
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water to give a chloroform layer which was subjected to silica gel column chromatography
(ethyl acetate/n-hexane, stepwise). Zerumbone in 5% ethyl acetate fraction was recrystallized
from methanol Abs were obtained from the following sources: mouse anti-ubiquitin, rabbit
anti-HSF1, and anti-rabbit horseradish peroxidase (HRP)-linked IgG Abs were from Cell Sig-
naling Technology (Beverly, MA); mouse anti-HSP70 Ab was from Enzo Biochem Inc. (New
York, NY); mouse anti-α-tubulin Ab was from EMD Bioscience (La Jolla, CA); goat anti-COX-
2, rabbit anti-iNOS, and goat anti-lamin B Abs were from Santa Cruz Biotechnology (Santa
Cruz, CA); and HRP-conjugated anti-mouse and HRP-conjugated anti-goat Abs were from
DAKO (Tokyo, Japan). siRNAs and LipofectamineTM RNAiMAX were purchased from Invi-
trogen (Carlsbad, CA). LPS (Salmonella enterica serotype typhimurium) was purchased from
Sigma-Aldrich (St. Louis, MO) and 4-phenyl butyric acid (PBA) from Cayman Chemical (Ann
Arbor, MI). All other chemicals were purchased fromWako Pure Chemicals (Osaka, Japan),
unless specified otherwise.
Cell culture
RAW264.7 murine macrophages were purchased from the American Type Culture Collection
(Rockville, MD). The cells were grown in DMEM supplemented with 10% heat-inactivated FBS
and streptomycin (100 μg/mL) at 37°C in a humidified atmosphere of 95% air and 5% CO2.
Western blot analysis
Cells were treated with the sample or vehicle [0.5% dimethyl sulfoxide (DMSO), v/v] for vari-
ous times, then lysed in BioPlex cell lysis buffer (Bio-Rad Laboratories, Hercules, CA) (1% pro-
tease inhibitor cocktail, v/v). Proteins were detected using the appropriate specific primary Ab
(1:2000), followed by the corresponding HOURP-conjugated secondary Ab (1:2000), as previ-
ously described [10].
Filter trap assay
Filter trap assays were performed as previously reported [19]. Briefly, cells were seeded into
35-mm dishes and treated with the sample or vehicle for various times, then lysed in an ice-cold
lysis buffer (20 mMTris-HCl, pH 7.5; 137 mMNaCl; 1 mM ethylene glycol tetraacetic acid; 10%
glycerol; 2% protease inhibitor cocktail; 1% protease inhibitor cocktail; 1% Tween 20, v/v) and
collected by scraping. Samples were incubated on ice for 15 minutes, and then centrifuged for 10
minutes at 19,000 x g at 4°C. The chambers of a 96-well Dot-blot system (Bio-Dot1Microfiltra-
tion apparatus, Bio-Rad Laboratories, Hercules, CA) were covered with Immobilon-P mem-
branes (upper) and filter paper (lower), which were pre-wetted with normalizing buffer, to
establish a dot-blot system. After normalizing the samples to 1 μg/μL of protein with normalizing
buffer (2% sodium dodecyl sulfate; 10 mM Tris-ethylenediaminetetraacetic acid, pH 7.5), each
sample (100 μL) was loaded into the respective wells and vacuumed until all exited through the
membrane. The membranes were subjected to western blot analysis, as described above, using
anti-ubiquitin and anti-zerumbone-adducts Abs.
Determination of nitrite concentration by Griess assay
The nitrite concentrations in media supernatants were determined by Griess reaction [20].
Cells were seeded into 96-well plates were treated with zerumbone or the vehicle for 1 hour
before exposure to LPS (100 ng/mL) for 24 hours. Each supernatant was mixed with Griess
reagent [1% sulfanilamide in 5% phosphoric acid, 0.1% N-(1-naphthyl) ethylenediamine dihy-
drochloride]. Absorbance of the reaction mixture was measured at 540 nm.
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Determination of the concentrations of TNF-α, IL-6, and IL-1β by
enzyme-linked immunosorbent assay (ELISA)
Cells were seeded into 96-well plates, and treated with the sample or vehicle for 24 hours. Con-
centrations of tumor necrosis factor (TNF)-α, IL-6, and IL-1β in supernatants were quantified
using an ELISA kit (eBioscience, San Diego, CA), according to the manufacturer’s instructions.
The supernatants were diluted by 300- and 100-fold for TNF-α and IL-6, respectively, whereas
there was no dilution for IL-1β.
Nuclear-cytoplasmic fractionation
Cells were seeded into 35-mm dishes and treated with zerumbone or the vehicle for various times,
or with heat at 43°C, then subjected to nuclear-cytoplasmic fractionation using an NE-PER Nuclear
and Cytoplasmic Extraction Reagents Kit (Thermo Fisher Scientific, Wilmington, DE), according
to the manufacture’s protocol. Each fraction was subjected to western blot analysis.
RNA interference of HSF1
Transfection of siRNAs was performed using LipofectamineTM RNAiMAX, according to the
manufacturer’s specifications. Briefly, after RAW264.7 cells were seeded into 24-well plates,
each siRNA solution was added to LipofectamineTM RNAiMAX solution (1:25), then incu-
bated for 20 min in serum-free Opti-MEM1. Then, this transfection mixture was diluted in
serum-free Opti-MEM1 (final concentration of siRNA 10 nM), then cells were added and
incubated for 6 hours. After replacing the medium with DMEM containing 10% FBS, the cells
were incubated for another 24 hours.
Quantitative real-time RT-PCR
Cells were seeded into 24-well plates, and treated with the sample or vehicle for 6 hours. Total
RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA). The amount and purity of
RNA were assessed by spectrophotometry using a SmartSpec1 3000 Spectrophotometer
(BioRad Laboratories). cDNA was synthesized using 1 μg total RNA with an RNA PCR Kit
(AMV). Thermal cycling was performed using a 7300 Real-Time PCR system with SYBR green
PCR mix (Applied Biosystems, Foster City, CA). The PCR conditions were as follows: 30°C for
10 minutes, 55°C for 30 minutes, 95°C for 5 minutes, and 4°C for 15 minutes. The primer
(Sigma-Aldrich) sequences are summarized in Table 1.
Statistical analysis
Each experiment was performed at least 3 times and values are shown as the mean±SE, as
appropriate. Statistically significant differences between groups for each assay were determined
using Student’s t-test. Differences were considered to be significant at p< 0.05.
Results
Induction of proteo-stress by zerumbone in RAW264.7
We recently reported that zerumbone non-specifically reacted with protein cysteine residues to
form thiol ethers in Hepa1c1c7 mouse hepatocytes [10]. To confirm its reactivity to cellular
proteins in RAW264.7 mouse macrophages, we treated those cells with the vehicle alone or zer-
umbone for 6 hours, then cell lysates were subjected to western blotting with an Ab against zer-
umbone-adducts. The amounts of zerumbone-modified proteins were markedly increased in a
concentration-dependent manner (Fig 1A). Next, we performed a filter trap assay with that Ab
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to investigate whether zerumbone increases protein aggregates, and found that treatment with
zerumbone for 6 or 12 hours dramatically increased protein aggregates containing zerumbone-
adducts (Fig 1B). Since abnormal proteins generated in the cytoplasm are known to undergo
ubiquitination for their degradation [13], we conducted a filter trap assay with an Ab against
ubiquitin. As shown in Fig 1C, both heat shock (HS) (43°C for 0–60 minutes) and zerumbone
(0–50 μM for 12 hours) increased the amounts of protein aggregates showing ubiquitination,
suggesting that zerumbone induces proteo-stress.
Contribution of proteo-stress induced by zerumbone to its anti-
inflammatory functions
To ascertain the involvement of proteo-stress induced by zerumbone in its anti-inflammatory
functions, we examined the suppressive effects of 2 different chemical reagents, N-acetyl-L-cys-
teine (NAC) and PBA on proteo-stress caused by zerumbone. NAC, an anti-oxidative nucleo-
phile, possesses a reactive thiol group, thus we considered that pretreatment with an excess
amount might competitively inhibit reactions between the thiol groups of proteins and zerum-
bone. We found that NAC notably inhibited protein aggregation induced by zerumbone,
including ubiquitinated (Fig 2A) and zerumbone-adduct (Fig 2B) proteins. It is important to
note that the suppressive effects of zerumbone on the expressions of COX-2 and iNOS protein,
together with nitric oxide (NO) suppressive activities, were also markedly declined by pretreat-
ment with NAC (Fig 2C).
PBA is an orally bioavailable chemical chaperone that has potential benefits as therapy for
protein folding diseases, such as Huntington’s disease and Alzheimer’s disease [21–23], and
has been reported to prevent protein aggregate accumulation and endoplasmic reticulum stress
[24]. Interestingly, our results showed that pretreatment with PBA decreased protein aggrega-
tion induced by zerumbone (Fig 2D). In addition, this agent also attenuated the suppressive
effects of zerumbone on COX-2 protein and NO generation, whereas it showed no effects on
iNOS protein expression (Fig 2E).
Promotion of nuclear translocation of HSF1 and increase of HSP70
expression by zerumbone
Transcriptional activation of HSF1 plays a key role in PQC systems by promoting HSR [25].
Translocation of HSF1 to the nucleus in response to HS or stress is tightly correlated with its
Table 1. Primers used for real-time RT-PCR
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phosphorylation, oligomerization, and DNA-binding activity [26]. As shown in Fig 3A, HS
treatment promoted nuclear translocation of HSF1. Next, we examined whether zerumbone
activates HSF1 in RAW264.7 cells. Zerumbone promoted nuclear translocation of HSF1 in a
treatment time-dependent manner, with similar results seen for geldanamycin, a specific inhib-
itor of HSP90 and potent inducer of HSPs that functions through HSF1 transactivation, used
as a positive control (Fig 3B). Following HSF1 translocation, treatment with HS, geldanamycin,
and zerumbone up-regulated inducible HSP70 expression (Fig 3C and 3D).
Fig 1. Zerumbone and HS induced proteo-stress. (A) RAW264.7 cells were treated with zerumbone (0–100 μM) for 6 hr, then lysed
for western blot analysis using anti-zerumbone-adducts Ab. (B) Cells were treated with zerumbone (0–50 μM) for 6 or 12 hr, then lysed
for filter trap assay using anti-zerumbone-adducts Ab. (C) Cells were treated with HS (incubation at 43°C in water bath) for 0–60 min or
zerumbone (0–50 μM for 12 hr, then lysed for filter trap assay using anti-ubiquitin Ab.
doi:10.1371/journal.pone.0161282.g001
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Anti-inflammatory functions by HSR inducers, HS and geldanamycin
Several reports have demonstrated that HSF1 activation and increment of expression of HSPs
are related to suppression of pro-inflammatory responses [17,27], thus we explored the anti-
inflammatory potential of HS and geldanamycin. HS treatment inhibited iNOS expression
induced by LPS, while the effect on COX-2 was weak (Fig 4A). Furthermore, geldanamycin
suppressed the expression of COX-2 and iNOS induced by LPS (Fig 4B), implying that HSF1
activation negatively regulates the expression of these pro-inflammatory mediators.
Attenuation of the suppressive effects of zerumbone on iNOS and IL-1β
induction by HSF1 down-regulation
To investigate the importance of HSF1 for the anti-inflammatory functions of zerumbone, we
down-regulated HSF1 expression using siRNA (Fig 5A), which resulted in attenuation of
HSP70 induction by zerumbone and geldanamycin (Fig 5B). We then examined the effects of
HSF1-knockdown on the expressions of pro-inflammatory genes induced by LPS, including
TNF-α, IL-6, IL-1β, iNOS, and COX-2, which revealed that mRNA expressions of IL-6 and
iNOS were notably increased by HSF1 knockdown (data not shown). Next, we pretreated with
zerumbone 1 hour prior to LPS stimulation to investigate the effects of HSF1 down-regulation
on the expressions of these pro-inflammatory genes. Although the suppression rates of mRNA
expression of TNF-α, IL-6, and COX-2 by zerumbone were not altered in HSF1-knockdown
cells, those of IL-1β and iNOS were significantly attenuated (Fig 5C). Similar to mRNA expres-
sions, HSF1 down-regulation also affected extracellular secretion of IL-1β protein, but not of
TNF-α or IL-6 (Fig 5D). Along a similar line, HSF1 down-regulation decreased the suppressive
activities of zerumbone on the expressions of iNOS and COX-2 (Fig 5E).
Discussion
Although diverse bioactivities of zerumbone have been reported [1–7], its mechanisms of
action have not been fully uncovered. We recently found that zerumbone specifically targets
Keap1 [2,8,9], while this agent binds to numerous proteins with low selectivity [10,11]. How-
ever, the role(s) of its non-specific interactions with cellular proteins remains to be clarified.
Therefore, in the present study, we examined the possibility that proteo-toxic stress induced by
zerumbone contributes to its anti-inflammatory functions.
Zerumbone increased protein aggregates in RAW264.7 cells, as indicated by filter trap assay
results (Fig 1). Furthermore, it promoted translocation of HSF1 to the nucleus and increased
protein expressions of HSP70, which were also shown by HS treatment (Fig 3). These findings
indicate that zerumbone possesses a property to denature cellular proteins, which may induce
HSR [10]. Interestingly, protein aggregates in cells treated with zerumbone for 12 hours were
less abundant as compared to after 6 hours (Fig 1B), implying activation of degradation
Fig 2. NAC and PBA attenuated both proteo-stress and anti-inflammatory functions of zerumbone. (A, B)
RAW264.7 cells were pretreated with NAC (0–10 mM) for 1 hr. After incubation of the cells with zerumbone (0,
50 μM) for another 12 hr, cells were lysed for filter trap assay using anti-ubiquitin and anti-zerumbone-adducts
Abs. (C) Cells were pretreated with NAC (0–10 mM) for 1 hr. After incubation of the cells with zerumbone (0–
10 μM) for another 1 hr, cells were exposed to LPS (100 ng/mL) for 12 hr. Then, cells were subjected to western
blot analysis using anti-COX-2, anti-iNOS, and anti-α-tubulin Abs. Also, after LPS stimulation for 24 hr, the
supernatants were subjected to Griess assay. *P < 0.001. (D) Cells were pretreated with PBA (0, 1 mM) for 1 hr.
After incubation of the cells with zerumbone (0, 50 μM) for another 12 hr, filter trap assay was done using anti-
ubiquitin and anti-zerumbone-adducts Abs. (E) Cells were pretreated with PBA (0, 1 mM) for 1 hr. After
incubation of the cells with zerumbone (0–10 μM) for another 1 hr, cells were exposed to LPS (100 ng/mL) for 12
hr. Then, cells were subjected to western blot analysis using anti-COX-2, anti-iNOS, and anti-α-tubulin Abs.
Also, after LPS stimulation for 24 hr, the supernatants were subjected to Griess assay. *P < 0.01.
doi:10.1371/journal.pone.0161282.g002
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systems against intracellular abnormal proteins, such as UPS and autophagy. In support of this
notion, we previously showed that zerumbone up-regulated the expressions of the 20S protea-
some subunit β5 and pro-autophagic gene p62 in Hepa1c1c mouse hepatocytes [11]. To evalu-
ate the involvement of proteo-stress induced by zerumbone in its anti-inflammatory functions,
we employed 2 different reagents that are considered to mitigate proteo-stress. NAC, used to
prevent zerumbone from reacting with protein thiols in a competitive manner, dramatically
suppressed increment of protein aggregates, and attenuated its suppressive activities toward
iNOS and COX-2 expressions and NO generation (Fig 2A–2C). However, NAC may also inter-
fere with zerumbone to react with Keap1, which is known to possess highly reactive thiol
groups [28], to attenuate Nrf2 activation by the agent. In addition, PBA, a reagent known to
mitigate proteo-stress without disturbing thiol modification, was used. Molecular chaperones
are major players in the PQC system and HSPs are their endogenous proteins, while there are
also low molecular-weight compounds termed chemical chaperones [24]. PBA is a chemical
chaperone that reduces accumulation of protein aggregates in vivo and in vitro and its hydro-
phobic moiety has been reported to interact with exposed hydrophobic segments of unfolded
protein to prevent aggregation [24]. This agent has also been shown to be beneficial when used
as the therapy for various proteo-toxic diseases, such as Alzheimer’s disease, Huntington’s dis-
ease, and Parkinson’s disease [21–23,29]. Interestingly, PBA treatment decreased protein
aggregation induced by zerumbone and attenuated its suppressive activity toward COX-2 pro-
tein expression, whereas iNOS expression was not altered (Fig 2D and 2E). Collectively, our
results suggest that proteo-stress induced by zerumbone partially contributes to its anti-inflam-
matory effects.
A number of studies have demonstrated that HSP overexpression may be a promising
approach for treatment of neurodegenerative [30] and inflammatory [31] diseases. Geldana-
mycin, a naturally occurring benzoquinone ansamycin that selectively binds to and inhibits
HSP90 to trigger HSR [32], has been demonstrated to suppress aggregation via induction of
molecular chaperones in various neurodegenerative diseases [33–35]. Interestingly, we found
that geldanamycin suppressed the protein expressions of COX-2 and iNOS in LPS-stimulated
RAW264.7 cells (Fig 4B). Kacimi et al. reported that HSP70 up-regulation induced by HSP90
binding agents including geldanamycin exerted neuroprotective and anti-inflammatory effects
in BV2 mouse microglia cells, and also noted that HSP90 inhibition by subsequent HSP70
induction blocked the anti-inflammatory effects of these agents induced by NF-κB [36]. Thus,
the suppressive effects of geldanamycin on COX-2 and iNOS protein expressions (Fig 4B) may
be associated with its HSP70 induction activity (Fig 3D).
HSR activation is orchestrated by HSF1, which transcripts hsp genes and rapidly induces
their expression in response to various types of stress [37]. In non-stressed conditions, HSF1 is
maintained in an inactive state by a direct association with HSP90. When cells are subjected to
HS or other proteo-toxic stress, the resulting increment of protein misfolding leads to HSP90
dissociation from HSF1, which allows HSF1 activation through its trimerization, phosphoryla-
tion, nuclear localization, and DNA-binding [15,16]. Present findings showed that zerumbone
Fig 3. Zerumbone and HS promoted nuclear translocation of HSF1 and induced HSP70 expressions.
(A, B) RAW264.7 cells were treated with the vehicle (DMSO), zerumbone (50 μM), or geldanamycin (1 μM)
for 0–3 hr, then subjected to Nuclear-cytoplasmic fractionation. Cells were lysed for western blot analysis
using anti-HSF1, anti-laminB (as a nucleus fraction marker), and anti-α-tubulin (cytoplasm) Abs. As a positive
control, cells were treated with HS (incubation at 43°C in water bath) for 60 min. (C) Cells were treated with or
without HS (incubation at 43°C in water bath) for 30 min. After recovery at 37°C for another 0–12 hr, cells
were lysed for western blot analysis using anti-HSP70 and anti-α-tubulin Abs. (D) Cells were treated with
vehicle (DMSO), zerumbone (50 μM), or geldanamycin (0.2, 1 μM) for 6–24 hr, then lysed for western blot
analysis using anti-HSP70 and anti-α-tubulin Abs.
doi:10.1371/journal.pone.0161282.g003
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promotes nuclear translocation of HSF1 in a time-dependent manner (Fig 3B), suggesting that
this agent is capable of activating HSF1. In support of that notion, we recently found that zer-
umbone induced HSF1 phosphorylation at Ser326 in a different cell line [10]. HSF1 plays a piv-
otal role in suppression of pro-inflammatory cytokine genes, including TNF-α [38], IL-6 [39],
and IL-1β [40], and our findings indicate that down-regulation of HSF1 leads to a marked
decrease in anti-inflammatory activity by zerumbone (Fig 5C–5E). Furthermore, Chen et al.
Fig 4. HS treatment and geldanamycin had anti-inflammatory functions. (A) RAW264.7 cells were treated with HS
(incubation at 43°C in water bath) for 30 min. After recovery at 37°C for another 0–6 hr, cells were lysed for western blot analysis
using anti-COX-2, anti-iNOS, and anti-α-tubulin Abs. (B) Cells were pretreated with geldanamycin (0–1 μM) for 6hr, then
exposed to LPS (100 ng/mL) for 12 hr. Then, cells were lysed for western blot analysis using anti-COX-2, anti-iNOS, and anti-α-
tubulin Abs.
doi:10.1371/journal.pone.0161282.g004
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reported that HSF1 down-regulation exacerbated pro-inflammatory activation of NF-κB and
AP-1 in vascular smooth muscle cells [17]. Also, in other studies, HSF1 repressed LPS-induced
transcription of the TNF-α and IL-1β genes via its direct interaction with the TNF-α5’-untrans-
lated region and nuclear factor of IL-6 respectively [38,40]. Furthermore, Takii et al. reported
that HSF1 induced expression of activating transcriptional factor (ATF) 3, which negatively
regulated IL-6 [39], and also showed that heat pretreatment inhibited LPS-induced expression
of 86% of the genes examined, and that HSF1-induced ATF3 activation played important roles
in iNOS and IL-6 suppressive activities following heat pretreatment [39]. Intriguingly, we pre-
viously reported that zerumbone did not affect the NFκB activity in LPS-stimulated
RAW264.7 macrophages [7]. Together, the present results and these findings suggest a signifi-
cant role of proteo-stress by zerumbone to exhibit its anti-inflammatory effects.
Recently, HSPs have attracted attention from researchers because of their therapeutic poten-
tial for patients with neurodegenerative and inflammatory diseases [30,31,41]. In this study, we
showed that moderate proteo-stress induced by zerumbone activates HSR, thereby contribut-
ing to its anti-inflammatory functions. Interestingly, Muralidharan et al. reported that moderate
alcohol-induced activation of HSF1 and induction of HSP70 inhibited pro-inflammatory cyto-
kines resulting in endotoxin tolerance [42]. It is well known that alcohol possesses a property to
denature proteins, which may be related to alcohol-induced HSF1 activation. In addition to HSP
expression, other PQC systems, including UPS and autophagy, may contribute to the anti-
inflammatory functions of zerumbone. Yao et al. reported that arctigenin, a natural dibenzylbu-
tyrolactone, promoted degradation of iNOS through proteasomes, in which the carboxyl termi-
nus of Hsc70-interecting protein (CHIP) played an important role [43]. CHIP, an E3 ubiquitin
ligase, associates with iNOS and induces its ubiquitination and degradation via proteasomes [44],
while it also promotes ubiquitination of unfolded proteins [45], which implies important roles of
protein degradation systems in anti-inflammatory activities of zerumbone. In our previous study,
we showed that zerumbone increased CHIP-dependent protein ubiquitination in mouse hepato-
cytes [11], suggesting that CHIPmay contribute to the iNOS suppressive activity of zerumbone,
though additional findings supporting this speculation are needed.
Conclusions
The present findings showed that proteo-stress induced by zerumbone activates HSF1 for
exhibiting its anti-inflammatory functions as well as other activities (Fig 6). In addition to this
unique mode of action, it is also important to note that the specific interaction of zerumbone
with Keap1 plays a significant role in its anti-inflammatory functions [8]. Various reports have
shown that several phytochemicals induce HSPs [46,47], thus HSR induction by phytochemi-
cals may partially account for the mechanisms underlying their anti-inflammatory functions.
This mode of action is distinct from those of molecular-targeted drugs.
Because bioavailability of zerumbone has been uncovered to be poor in a mouse model
(Murakami et al., unpublished data), its target site may be the gastrointestinal tract. This notion
Fig 5. HSF1 down-regulation partially attenuated the anti-inflammatory effects of zerumbone. (A) Cells were treated with
siRNA solution (control or HSF1 siRNA, 10 nM) for 6 hr. After recovery for another 24 hr, total RNA was subjected to qRT-PCR to
semi-quantify the expression of HSF1 and β-actin, or cells were lysed for western blot analysis using anti-HSF1 and anti-α-
tubulin Abs. (B) siRNA-transfected cells were pretreated with vehicle (DMSO), zerumbone (50 μM), or geldanamycin (1 μM) for
12 hr. Then, cells were lysed for western blot analysis using anti-HSF1, anti-HSP70, and anti-α-tubulin Abs. (C) siRNA-
transfected cells were pretreated with zerumbone (0, 2 μM) for 1 hr. Exposed to LPS (100 ng/mL) for 6 hr, total RNA was
subjected to qRT-PCR to semi-quantify the expression of TNF-α, IL-6, IL-1β, iNOS, and COX-2. (D) Exposed to LPS (100 ng/mL)
for 24 hr, the concentrations of TNF-α, IL-6, and IL-1β in the culture media were determined by ELISA. (E) siRNA-transfected
cells were pretreated with zerumbone (0–10 μM) for 1 hr, then exposed to LPS (100 ng/mL) for 12 hr. Cells were lysed for
western blot analysis using anti-COX-2, anti-iNOS and anti-α-tubulin Abs. *P < 0.05, **P <0.005 versus CTL.
doi:10.1371/journal.pone.0161282.g005
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is supported by our previous work showing that zerumbone effectively prevented inflamma-
tion-associated colon carcinogenesis in mice [5]. Regarding the toxicity of zerumbone, it
should be noted that Rahman et al. suggested that this agent has no apparent acute toxicity
because the 50% lethal dose of zerumbone-loaded nanostructure lipid carrier was found to be
higher than 200 mg/kg in BALB/c mice [48], although chronic toxicity should be examined in
the future. Collectively, clinical use of this phytochemical for the regulation of inflammation-
associated diseases in the gastrointestinal tract may warrant further investigation.
Supporting Information
S1 Data. All data of this work are available at https://figshare.com/s/bccc935c34bdd07fd073.
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